RGMA001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RGMA001, covering 2012-03-16 to 2012-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD) [NA]